Document is current
Any future updates will be listed below
-
Authors
Lustberg, Maryam B.
Kuderer, Nicole M. https://orcid.org/0000-0002-9263-8540
Desai, Aakash
Bergerot, Cristiane https://orcid.org/0000-0003-0037-0303
Lyman, Gary H. https://orcid.org/0000-0002-0823-8086
- License Information
-
More Information
Article History
Accepted: 26 April 2023
First Online: 25 May 2023
Competing interests
: M.B.L. is on the physician advisory board for Infinite Strength, Project Life and The Right Dose; has been a consultant for AstraZeneca, Lilly Novartis, Pfizer and Sanofi; and reports institutional research funding from Pfizer. N.M.K. reports being a consultant for BeyondSpring, BMS, G1 Therapeutics, Invitae, Janssen, Pfizer, Sandoz, Seattle Genetics, Spectrum and Total Health, all outside the submitted work. G.H.L. reports institutional research funding from Amgen; honoraria for lectures from ER Squibb, Frensenius Kabi, Kallyope, Merck, Partners Healthcare, Sandoz, Samsung and Seattle Genetics; and honoraria for consulting from BeyondSpring, G1 Therapeutics and Jazz Pharm. A.D. and C.B. declare no competing interests.
